Trump Announces Apple-Intel Partnership to Manufacture Chips in the U.S.
Apple will work with Intel to make chips in the U.S., reducing reliance on Asia and boosting Intel’s business and stock.
Apple will work with Intel to make chips in the U.S., reducing reliance on Asia and boosting Intel’s business and stock.
PepGen has Buy ratings; DM1 drug data mixed, big 2026 results could drive huge upside from very low stock price.
The deal will create a leading global payments platform combining payment acceptance and cross-border payouts across 190+ countries.
Publicis and The Trade Desk settled a fee dispute; TTD is again recommended after audit issues and industry tensions.
Adobe reported strong Q2 results and raised its full-year guidance, but shares fell after the company announced that CFO Dan Durn will step down on June 15 to pursue a new opportunity.
Adial Pharmaceuticals acquires Azora Therapeutics and raises up to $64 million to advance AT177, a novel colon-targeted therapy for ulcerative colitis. Phase 1 studies planned for mid-2027.